Utomilumab

DB15113InvestigationalProtein Based Therapies

Utomilumab is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).

Mechanism: Pharmacologically active on Tumor necrosis factor receptor superfamily member 9
Curator reviewed
Code names: PF-05082566 · PF-2566 · PF 5082566

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

17Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Utomilumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.